A phase II trial of extended induction galiximab ([G] anti-CD80 monoclonal antibody) plus rituximab (R) in previously untreated follicular lymphoma (FL): Initial report of CALGB study 50402
   Google Scholar   
Citation:
Ann. Oncol. vol 19 (suppl 4) abstr 143
Year:
2008
Type:
Abstract
Sub type:
Poster General
Funding:
NCTN
Endpoint:
Primary
Analysis:
Primary
Status:
Presented/Published
Citation Status:
pub
Note:
Methodological:
No
Biospecimen:
No
DataSharing:
No
Parents:
None
Children:
976  
Program:
OGC
Primary Committee:
Lymphoma
Sec. Committees:
   
Pharmas:
 
Grants:
 
Corr. Author:
 
Authors:
         
Study
CALGB-50402
Multiple Studies, or Legacy Studies in Alliance Study:
Phases:
2
Keywords: